BCL11B and nervous system disorder: A number of neurodegenerative and neurodevelopmental diseases, e.g., Alzheimer’s and autism spectrum disorder, are associated with a decrease in synaptic density suggesting that loss of Bcl11b/Ctip2 could contribute to these neurological disorders.